HUONS CO., LTD. Logo

HUONS CO., LTD.

Global healthcare company providing pharmaceuticals, medical devices, and wellness products.

243070 | KO

Overview

Corporate Details

ISIN(s):
KR7243070000
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 17 판교 아이스퀘어 A동 8층, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Huons Co., Ltd. is a global healthcare company established in 1965 with a mission of "making tomorrow healthier." The firm develops, manufactures, and supplies a wide range of medical solutions for human health. Its portfolio encompasses finished pharmaceutical products, including oral solid form drugs and eye drops, alongside medical devices and wellness items such as health supplements and cosmetics. As part of the Huons Group, the company prioritizes research and development to discover new growth engines and expand its international footprint. Huons is recognized for its cGMP-standard manufacturing facilities and a history of innovation, such as pioneering the first plastic injection container in Korea.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-18 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 3.7 MB
2025-08-13 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 10.8 KB
2025-08-06 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2025-08-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (중간배당)
Korean 8.9 KB
2025-08-06 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 17.9 KB
2025-07-29 00:00
Report Publication Announcement
결산실적공시예고
Korean 4.4 KB
2025-06-27 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-06-20 00:00
Regulatory News Service
신탁계약해지결과보고서
Korean 22.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.1 MB
2025-05-08 00:00
M&A Activity
합병등종료보고서(분할)
Korean 54.4 KB
2025-05-02 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 17.4 KB
2025-04-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 112.9 KB
2025-04-25 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-04-25 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB

Automate Your Workflow. Get a real-time feed of all HUONS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HUONS CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HUONS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Shedir Pharma Group Logo
Develops and sells pharmaceutical, nutraceutical, and dermo-cosmetic products in Italy & Spain.
Italy
SHE
SHIELD THERAPEUTICS PLC Logo
Commercializing a novel oral therapy for adults with iron deficiency.
United Kingdom
STX
SHINPOONG PHARMACEUTICAL CO.,LTD Logo
R&D-driven pharma firm making APIs, finished drugs, and medical products for global markets.
South Korea
019170
Shionogi & Co.,Ltd. Logo
A research-driven pharmaceutical firm creating drugs, diagnostics, and devices for global health.
Japan
4507
Shuttle Pharmaceuticals Holdings, Inc. Logo
Develops drugs to enhance radiation therapy for cancer and offers predictive diagnostics.
United States of America
SHPH
Siegfried Holding AG Logo
Global CDMO providing development and manufacturing of APIs and finished drugs for the pharma industry.
Switzerland
SFZN
SIGA TECHNOLOGIES INC Logo
Develops antiviral drugs for global health security against biothreats and infectious diseases.
United States of America
SIGA
Silexion Therapeutics Corp Logo
Developing a local drug delivery platform to treat KRAS-driven cancers and solid tumors.
United States of America
SLXN
Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.
South Korea
215600
Silo Pharma, Inc. Logo
Develops novel psychedelic & traditional therapies for pain and central nervous system disorders.
United States of America
SILO

Talk to a Data Expert

Have a question? We'll get back to you promptly.